The Research and Development team at Xap Therapeutics focuses on pioneering advancements in cell therapeutics using synthetic biology. This team is responsible for designing, developing, and optimizing genetically engineered "chassis" cells that serve as the foundation for innovative cell therapy treatments. Their work includes upstream research, cell line engineering, and continuous improvement of platform technologies to revolutionize therapeutic outcomes.
Carly Kempster
Scientist
Celeste Pallant
Principal Scientist
Ceyda Ugurlu
Senior Research Associate
Geoffrey De Oliveira
Scientist - Upstream
Hung-Ju Chang
Senior Scientist
Iwo Kucinski
Principal Scientist
Joseph Mortimer
Principal Scientist
Khashayar Khoshrou
Senior Research Associate
Kyriakoulla Panayi
Research Associate
Paola Colaco Osorio
Senior Research Associate
View all